×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
TENX – tenax therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
TENX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/2
03:46 pm
tenx
Tenax Therapeutics (NASDAQ:TENX) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Tenax Therapeutics (NASDAQ:TENX) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
11/25
01:57 pm
tenx
Tenax Therapeutics (NASDAQ:TENX) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Tenax Therapeutics (NASDAQ:TENX) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
11/25
08:01 am
tenx
Tenax Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
Tenax Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
11/25
07:00 am
tenx
Tenax Therapeutics to Participate in Upcoming Investor Conferences
Low
Report
Tenax Therapeutics to Participate in Upcoming Investor Conferences
11/13
09:36 pm
tenx
Tenax Therapeutics, Inc. (TENX) Discusses Scientific Rationale and Development Strategy for TNX-103 in PH-HFpEF Transcript [Seeking Alpha]
Low
Report
Tenax Therapeutics, Inc. (TENX) Discusses Scientific Rationale and Development Strategy for TNX-103 in PH-HFpEF Transcript [Seeking Alpha]
11/13
12:50 am
tenx
Tenax Therapeutics GAAP EPS of -$0.40 beats by $0.72 [Seeking Alpha]
Medium
Report
Tenax Therapeutics GAAP EPS of -$0.40 beats by $0.72 [Seeking Alpha]
11/12
04:53 pm
tenx
Tenax Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
Medium
Report
Tenax Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
11/12
04:05 pm
tenx
Tenax Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Medium
Report
Tenax Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/5
05:46 pm
tenx
Form 4 TENAX THERAPEUTICS, INC. For: Dec 02 Filed by: Rich Stuart
Neutral
Report
Form 4 TENAX THERAPEUTICS, INC. For: Dec 02 Filed by: Rich Stuart
12/5
04:52 pm
tenx
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Ikarian Capital, LLC
Low
Report
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Ikarian Capital, LLC
11/20
06:39 pm
tenx
Form 4 TENAX THERAPEUTICS, INC. For: Nov 18 Filed by: Giordano Christopher Thomas
Medium
Report
Form 4 TENAX THERAPEUTICS, INC. For: Nov 18 Filed by: Giordano Christopher Thomas
11/20
06:17 pm
tenx
Form 4/A TENAX THERAPEUTICS, INC. For: Nov 17 Filed by: Almenoff June Sherie
Medium
Report
Form 4/A TENAX THERAPEUTICS, INC. For: Nov 17 Filed by: Almenoff June Sherie
11/19
07:02 pm
tenx
Form 4 TENAX THERAPEUTICS, INC. For: Nov 17 Filed by: MCGAULEY THOMAS
Medium
Report
Form 4 TENAX THERAPEUTICS, INC. For: Nov 17 Filed by: MCGAULEY THOMAS
11/19
06:44 pm
tenx
Form 4 TENAX THERAPEUTICS, INC. For: Nov 17 Filed by: Almenoff June Sherie
Medium
Report
Form 4 TENAX THERAPEUTICS, INC. For: Nov 17 Filed by: Almenoff June Sherie
11/14
05:39 pm
tenx
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Venrock Healthcare Capital Partners III, L.P.
Medium
Report
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Venrock Healthcare Capital Partners III, L.P.
11/14
04:14 pm
tenx
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Lind Global Fund II LP
Medium
Report
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Lind Global Fund II LP
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
10/31
Tenax Therapeutics Provides Update on Phase 2 Pulmonary Hypertension Clinical Trial
7.4%
1/15 Tenax Therapeutics Inc (NASDAQ: TENX) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. 4.8%
6/14 Form 8-K TENAX THERAPEUTICS, INC. For: Jun 13 4.7%
1/22 Tenax Therapeutics Inc (NASDAQ: TENX) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 4.3%
8/23 Tenax Therapeutics Provides Clinical Development Update 3.4%
8/30 Form S-8 TENAX THERAPEUTICS, INC. 2.5%
11/8 Form 8-K/A TENAX THERAPEUTICS, INC. For: Jun 13 2.5%
4/29 Form 8-K TENAX THERAPEUTICS, INC. For: Apr 24 2.3%
3/30 Form 10-K TENAX THERAPEUTICS, INC. For: Dec 31 2.1%
2/14 Form SC 13G/A TENAX THERAPEUTICS, INC. Filed by: Iroquois Capital Management, LLC 0.0%
1/15 Tenax Therapeutics Inc (NASDAQ: TENX) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. 4.8%
6/14 Form 8-K TENAX THERAPEUTICS, INC. For: Jun 13 4.7%
1/22 Tenax Therapeutics Inc (NASDAQ: TENX) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 4.3%
8/23 Tenax Therapeutics Provides Clinical Development Update 3.4%
8/30 Form S-8 TENAX THERAPEUTICS, INC. 2.5%
11/8 Form 8-K/A TENAX THERAPEUTICS, INC. For: Jun 13 2.5%
4/29 Form 8-K TENAX THERAPEUTICS, INC. For: Apr 24 2.3%
3/30 Form 10-K TENAX THERAPEUTICS, INC. For: Dec 31 2.1%
2/14 Form SC 13G/A TENAX THERAPEUTICS, INC. Filed by: Iroquois Capital Management, LLC 0.0%
TOP News Decliners
3/13
Form 8-K TENAX THERAPEUTICS, INC. For: Mar 11
-35.8%
2/29 Tenax Therapeutics Inc (NASDAQ: TENX) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -10.8%
1/13 Form 8-K TENAX THERAPEUTICS, INC. For: Jan 13 -7.9%
4/9 Tenax Therapeutics Announces Last Patient Completes Final Visit in its Phase 2 “HELP Study” of Levosimendan for Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction -6.7%
2/21 Tenax Announces the Addition of Mayo Clinic Expert, Dr. Barry Borlaug, to Scientific Advisory Board -5.8%
2/7 Form SC 13G TENAX THERAPEUTICS, INC. Filed by: BlackRock Inc. -5.7%
3/27 Form D TENAX THERAPEUTICS, INC. -5.6%
5/15 Q1/2019 3/31/2019 EPS -0.330 ZacksConsensus N/A ActVsEst N/A - N/A -4.2%
8/14 Q2/2019 6/30/2019 EPS -0.280 ZacksConsensus -0.450 ActVsEst 0.170 - Beat -4.2%
3/23 Form SC 13G TENAX THERAPEUTICS, INC. Filed by: ARMISTICE CAPITAL, LLC -2.0%
2/29 Tenax Therapeutics Inc (NASDAQ: TENX) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -10.8%
1/13 Form 8-K TENAX THERAPEUTICS, INC. For: Jan 13 -7.9%
4/9 Tenax Therapeutics Announces Last Patient Completes Final Visit in its Phase 2 “HELP Study” of Levosimendan for Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction -6.7%
2/21 Tenax Announces the Addition of Mayo Clinic Expert, Dr. Barry Borlaug, to Scientific Advisory Board -5.8%
2/7 Form SC 13G TENAX THERAPEUTICS, INC. Filed by: BlackRock Inc. -5.7%
3/27 Form D TENAX THERAPEUTICS, INC. -5.6%
5/15 Q1/2019 3/31/2019 EPS -0.330 ZacksConsensus N/A ActVsEst N/A - N/A -4.2%
8/14 Q2/2019 6/30/2019 EPS -0.280 ZacksConsensus -0.450 ActVsEst 0.170 - Beat -4.2%
3/23 Form SC 13G TENAX THERAPEUTICS, INC. Filed by: ARMISTICE CAPITAL, LLC -2.0%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: